Sandoz Group AG (VIE:SDZ)

Market Cap	29.94B +61.9%
Revenue (ttm)	9.50B +7.4%
Net Income	778.45M
EPS	1.78
Shares Out	n/a
PE Ratio	38.47
Forward PE	19.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	371
Open	68.98
Previous Close	68.92
Day's Range	68.98 - 68.98
52-Week Range	52.52 - 78.84
Beta	n/a
RSI	45.69
Earnings Date	Feb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 22,356
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: SDZ

Financial Performance

Financial numbers in USD